This statement was developed to promote international consensus on the definition of
borderline resectable pancreatic ductal adenocarcinoma (BR-PDAC) which was adopted by
the National Comprehensive Cancer Network (NCCN) in 2006, but which has changed
yearly and become more complicated. Based on a symposium held during the 20th meeting
of the International Association of Pancreatology (IAP) in Sendai, Japan, in 2016, the
presenters sought consensus on issues related to BR-PDAC. We defined patients with BR�…